equity investment
Bruker Takes Majority Stake in Proteomics Tech Firm Biognosys
With Bruker's investments, Biognosys said that it plans to open a US-based advanced proteomics contract research services lab.
Prenetics to Take Majority Stake in ACT Genomics
ACT provides a range of genomic testing services for major solid tumor types, as well as biomarker discovery and company diagnostic development services.
Microba Life Sciences to Sell 20 Percent Stake to Sonic Healthcare
The companies are also finalizing a strategic alliance to distribute Microba's microbiome testing products in a number of international markets.
Seqera Labs Closes €22M Series A Investment Round
The Spanish company has also taken control of the Nextflow DNA analysis programming framework that its founders created at the Centre for Genomic Regulation in Barcelona.
The new company is touting its new G.nome software as a "no-code" bioinformatics platform for managing genomic data workflows.